Stoke Therapeutics Inc. (Nasdaq: STOK) has pulled in Biogen (Nasdaq: BIIB) to help it develop and commercialize a treatment ...

Stoke Therapeutics Inc. and Biogen Inc. said Tuesday they are entering a collaboration to develop and commercialize a ...

Biogen (NASDAQ:BIIB) and Stoke Therapeutics (NASDAQ:STOK) said on Tuesday they are collaborating to develop and commercialize ...

A man and a woman who died when their car collided with a lorry on the A500 in Cheshire were from Stoke-on-Trent, police have ...

Stoke City have won just one of their past five league games against Swansea City (D3 L1), and have failed to score in their ...

When you buy through links on our articles, Future and its syndication partners may earn a commission.

Unsurprisingly, early retail listings for the new Nvidia card are causing spit-takes over high prices. That said, comparing ...

Stoke City forward Nathan Lowe says he puts his impressive first half of the season down to seeing a sports psychologist.

Biogen and Stoke partner on zorevunersen for Dravet syndrome, with a Phase 3 trial starting in 2025. Stoke gets $165 million ...

Discover Stoke Therapeutics' innovative RNA-based treatments like zorevunersen for Dravet syndrome, with a promising pipeline ...

H.C. Wainwright raised the firm’s price target on Stoke Therapeutics (STOK) to $47 from $35 and keeps a Buy rating on the shares. Stoke and ...

Stoke City midfielder Ben Pearson appreciates what he's been missing after making a return from long-term injury ...